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Abstract
Aim: Labor is one of the most painful experiences a woman may face during her lifetime. One of the most effective 
methods used for eliminating this pain is epidural analgesia. The aim of this study to determine the impact of adding 
morphine to low‑dose bupivacaine epidural anesthesia on labor and neonatal outcomes, and maternal side effects.
Materials and Methods: This is a prospective randomized double‑blind study comparing two regimens of anesthetic 
agents used for epidural anesthesia in labor. A total of 120 pregnant women were randomized into two groups with 60 
subjects in each study arm. A catheter was inserted, and 0.1% bupivacaine + 2 µg/mL fentanyl in 15 mL saline were 
given to Group bupivacaine‑fentanyl (Group BF), while 0.0625% bupivacaine + 2 µg/ml fentanyl + 2 mg morphine in 
15 mL saline were given to Group bupivacaine‑fentanyl‑morphine (Group BFM) with no test dosing from the needle. 
No morphine was added to the subsequent epidural injections in Group BFM.
Results: The  total  dose of bupivacaine was significantly  lower  in Group BFM  relative  to Group BF  (P = 0.0001). 
The visual  analogu  scalescores at  15,  30,  and 45 min were  significantly  lower  in Group BF compared  to  thosein 
Group BFM (P = 0.0001, P = 0.001, and P = 0.006, respectively). The second stage of labor was significantly shorter in 
Group BFM relative to Group BF (P = 0.027 and P = 0.003, respectively). The satisfaction with analgesia following the 
first dose was higher in the nonmorphine group (P = 0.0001). However, maternal postpartum satisfaction was similar 
in both groups. Either nausea or vomiting was recorded in eight patients in Group BFM.
Conclusion: We believe that epidural analgesia comprised of a low‑dose local anaesthetic and 2 mg morphine 
provides a painless labor that significantly reducesthe use of local anesthetic without changing the efficiency of the 
analgesic, ensuring the mother’s satisfaction without leading to an adverse effect on the mother or foetus, while mildly 
(but significantly) shortening the second stage of labor.
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Introduction
A variety of methods can be used to provide painless labor by 
reducing the pain resulting from uterine contractions during 
labor, with no influence on the power of the contractions. 
Regional analgesia has become the most common method 
of pain relief used during labor in many countries.[1,2] One 
of the most widely used methods for relief of labor pain is 
epidural analgesia.[3] Implementation of epidural analgesia, 
an epidural catheter is inserted into the epidural space and a 
continuous infusion or multiple injections of local anesthetic 
were given according to the patient’s pain level.[4] Local 
anesthetics commonly used for epidural analgesia include 
bupivacaine and ropivacaine and opioids, such as morphine 
and fentanyl. In conventional epidural analgesia, ahigh 
concentration of local anesthetic is used alone, ensuring 
a deep motor block.[5] Epidural opioids ensure analgesia 
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without a motor block; however, when they are used alone, 
they do not lead to a satisfactory analgesia throughout 
labor.[6‑8] When the two drugs are combined, both the 
local anesthetic and opioids can be administered at low 
concentrations, resulting in increased maternal satisfaction 
and most importantly, a decrease in the incidence of adverse 
effects such as hypotension and drug toxicity.[9]
In the current study, our primary aim is to determine the 
impact of adding morphine to low‑dose bupivacaine epidural 
anesthesia on labor and neonatal outcomes, and maternal 
side effects.
Materials and Methods
The current study was conducted on 120 pregnant 
multiparous women who presented in spontaneous labor. 
Written consent was obtained from all patients. The study 
was approved by Ataturk University Ethics Committee 
and was conducted in a double‑blind fashion with the 
association of obstetricians.
The study was conducted with multiparous pregnant women 
who were in the American Society of Anesthesiologists (ASA) 
physical status I‑II group, at 37‑42 weeks of gestation, 
cervical dilatation of 3.5 cm, between 16 and 30 years of 
age and had request for labor analgesia. All foetuses were 
singlewith vertex presentation and had normal heart rate 
pattern status. The criteria for exclusion from the study 
were as follows: Nulliparity, a history of sensitivity or allergy 
against/to amide local anesthetics, any contraindication 
to fentanyl or morphine, previous use of any intravenous 
opioid agonist or antagonist, contraindication to regional 
anesthesia, preeclampsia, any cardiovascular disease, a 
serious hypertension or hemorrhage during pregnancy, 
a body mass index (BMI) >30, intrauterine growth 
retardation, foetal distress, a multiple pregnancy, nonvertex 
presentation, nausea, or vomiting. Induction of labor 
in all women was done with artificial rupture of foetal 
membranes (when the cervix was 3 cm dilated) and syntocin 
on infusion (6 mIU/min). According to maternal or fetal 
indications, cesarean delivery was applied.
Randomization was performed the start of the study 
using computer software. The patients were randomized 
into two groups with 60 subjects each. Maternal oxygen 
saturation, heart rate, noninvasive blood pressure, and 
fetal heart rate were monitored during labor. All epidural 
catheters (Perifix® soft tip 701 Filter set, Braun, Melsungen) 
were inserted via the L2‑3, L3‑4, or L4‑5 intervertebral 
space with an 18‑gauge Tuohy needle using the hanging 
drop technique when the cervical dilatation was 3.5‑6 cm 
and with the patient in a sitting position. The catheter 
was fixed at 3‑5 cm in the epidural space. A dose of 0.1% 
bupivacaine + fentanyl was administered to the subjects in 
Group bupivacaine‑fentanyl (Group BF), and the subjects 
in Group bupivacaine‑fentanyl‑morphine (Group BFM) 
received 0.0625% bupivacaine + fentanyl + morphine.
If the patient’s visual analog scale (VAS) score ≥40, 
asolution of 0.1% bupivacaine + 2 µg/cc fentanyl in 15 mL 
saline was givenrandomly to Group BF, while a solution of 
0.0625% bupivacaine + 2µg/cc fentanyl + 2 mg morphine in 
15 mL saline was givenrandomly to Group BFM without any 
test dosing. Additional doses were administered according 
to scores of VAS (VAS score ≥40). In Group BFM, the 
additional doses did not include morphine. The study 
solution was prepared by an anesthesiologistwith no direct 
involvement in the patient’s care or data collection, and the 
investigators and patients were blinded as to the solution 
type.
The pain felt by patients was evaluated using the VAS 
score at a 15‑min interval (0 = No pain, 100 = Worst 
possible pain). A VAS score of 40 or above was regarded 
as insufficient analgesia, and 10 mL of solution was 
administered. AVAS score of below 40 was regarded as 
sufficient analgesia. The degree of motor block in the lower 
extremities was evaluated once every 30 min using the 
Bromage scale (1: No pain at the lower extremity. 2: Ankle 
is able to perform flexion. 3: Knee joint is able to perform 
flexion. 4: Flexion is present at the hip in a supine position. 
5: Patient is able to stand. 6: Patient is able to stand and 
bend her knee).
Variables collected for each patient were age, height, weight, 
BMI, satisfaction from analgesia following the first dose, 
total dose of bupivacaine and fentanyl, Bromage score once 
every 30 min, incidence of instrumental vaginal delivery, 
duration of labor stages, total duration of delivery, patient 
satisfaction following delivery, total doses of oxytocin and 
morphine‑derived side effects during labor and postpartum 
period (respiratory depression, nausea, vomiting, itching, 
sedation, whether urinary retention and neurological 
deficit). Postoperative urinary retention was defined as the 
inability to void in the presence of a full bladder.[10] After 
delivery of the baby, controlled cord traction was done by 
obstetrician, then the placental side of the divided umbilical 
cord was doubly clamped and then blood was drawn from 
the umbilical artery for the measurement of pH and an 
infusion of oxitocin was started (20 IU per 500 mL at rate 
of 60‑100 mL/h). Moreover, although the VAS score was 
evaluated once every 15 min, recordings were only obtained 
once every 15 min for the 1st h, once every 30 min for the 
2nd h, and once an hour for the remaining period. If the 
respiration rate was below 10/min, respiratory depression 
was to be considered. If the systolic arterial pressure was 
below 100 mmHg or lower than 20% of the baseline level, 
hypotension was to be considered. Additionally, evaluation 
of sedation was regarded as follows: None (alertness), 
mild (somnolence), moderate (sleepy), and severe. The level 
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of maternal satisfaction was assessed as poor, moderate, or 
good. The patients were monitored for 24 h for respiratory 
depression and sedation. The Apgar score at the1st and 
5th min, the pH of the umbilical artery, and the requirements 
for tracheal intubation and ventilation were also recorded.
The power calculations were based on the preliminary 
study, the median dose of bupivacaine was determined 
as 48 mg (SD 15 mg) in the group that received 2 µg/cc 
fentanyl with 0.1% bupivacaine. We predicted a reduction 
ofthe requirement for bupivacaine by 20% by reducing 
the dose of bupivacaine to 0.00625% and adding 2 mg 
morphine (a difference of 9.6 mg). On the basis of the 
assumption that the α error is 0.05 and the β error is 0.10, 
the estimated number of patients required is 52, with a 
power of 80%. The sample size in our study determined 
according to these results as 60 patients.
Statistical analysis
Data were analyzed using SPSS 10.0 statistical software. Age, 
height, weight, BMI, duration of the labor stages, duration of 
delivery, foetal outcomes, VAS scores, and administered total 
dose of bupivacaine and fentanyl of patients and whether 
the motor block, hypotension, itching, urinary retention, 
respiratory depression, neurological deficit, satisfaction with 
the analgesia, nausea, and vomiting were analyzed with 
appropriate statistical tests. The Komogorov‑Smirnov test 
was used to assess the normal distribution of data. If data 
werenot normally distributed, comparisons were determined 
using Mann‑Whitney U‑test, Student’s t‑test was used for 
normally distributed continuous variables. Chi‑square test 
was used to compare categorical variables. A “P” value below 
0.05 is regarded as statistically significant.
Results
A total of 120 term multiparous women in spontaneous 
labor were included to this study (60 patients in each group). 
Patient details were similar for the two groups [Table 1]. The 
VAS scores at the 15th, 30th, and 45th min were significantly 
lower in Group BFthan in Group BFM (P = 0.0001, 
P = 0.001, P = 0.006, respectively) and no difference were 
observed between two groups in terms of VAS scores after 
the first 45 min [Table 2].
Satis fact ion from analgesia fol lowing the f i rst 
dose was significantly better in Group BF than in 
Group BFM (P = 0.0001), while no statistically significant 
difference was detected between Group BF and Group BFM 
in terms of maternal the postnatal satisfaction [Table 3]. The 
total dose of bupivacaine administered was significantly lower 
in Group BFM compared to that of Group BF (P = 0.0001). 
No statistically significant difference was detected between 
Group BF and Group BFM regarding motor block or foetal 
outcomes. There was no significant difference between 
the two groups regarding the duration of the 1st stage of 
delivery or total duration, while the second and third stages 
of labor were significantly shorter in Group BFM relative 
to Group BF (P = 0.027 and P = 0.003, respectively). 
Total oxytocin doses in two groups were found to be 
similar [Table 4]. None of the babies required ventilation or 
intubation. There was no hypotension, itching, respiratory 
depression, urinary retention, sedation, and neurological 
deficit in groups. None of women in Group BF had nausea 
and vomiting although eight women in Group BFM had 
nausea and vomiting. Regarding side effects, the instance of 
nausea and vomiting was significantly higher in Group BFM 
than in Group BF (P = 0.003). None of patients required 
instrumental delivery.
Table 1: Patient’s details
BF BFM P value
Age (years) 26.0±3.50 25.2±2.85 0.056
Weight (kg) 70.9±6.25 71.0±7.81 0.938
Height (cm) 160.9±2.89 61.4±5.28 0.494
BMI 27.0±2.40 26.8±2.40 0.685
Parity 2.24±0.96 2.31±0.47 0.060
All values are expressed as the mean±standard deviation; BF=Bupivacaine, 
fentanyl group; BFM=Bupivacaine, fentanyl, and morphine group, BMI=Body 
mass index
Table 2: Visual analog scale scores
Time (min) Group BF Group BFM P value
15th 15.26±17.3 31.4±26.0 0.0001*
30th 12.8±11.7 24.5±23.0 0.001*
45th 12.6±12.4 19.6±13.9 0.006*
60th 17.1±12.5 22.7±17.7 0.06
90th 19.0±13.8 24.2±20.7 0.181
120th 24.7±15.5 25.9±15.3 0.705
180th 21.0±13.4 25.8±16.7 0.177
240th 17.5±7.6 20.0±7.2 0.190
300th 23.3±8.7 21.0±11.2 0.427
360th 30.0±18.6 28.2±11.4 0.711
420th 26.7±16.4 26.7±12.6 1.000
All values are expressed as the mean±standard deviation; BF=Bupivacaine, 
fentanyl group; BFM=Bupivacaine, fentanyl, and morphine group; The visual 
analog scale scores at the 15th, 30th, and 45th min demonstrate a significant 
reduction in Group bupivacaine, fentanyl compared with group bupivacaine, 
fentanyl, and morphine (P=0,0001, P=0.001, P=0.006)
Table 3: Characteristics of epidural procedure
BF BFM P value
Satisfaction from analgesia following the first dose







BF=Bupivacaine, fentanyl group; BFM=Bupivacaine, fentanyl, and morphine 
group; There is a significant difference in group bupivacaine, fentanyl relative 
to group bupivacaine, fentanyl, and morphine in terms of patient satisfaction 
following the first dose, P=0.0001
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Discussion
This prospective, randomized, and double‑blind study 
comparing 0.1% bupivacaine + 2 µg/cc fentanyl with 
0.0625% bupivacaine + 2 µg/cc fentanyl + 2 mg morphine 
demonstrated a significantly lower total dose of the local 
anesthetic administered to the morphine group without 
a change to the analgesic efficiency. Studies conducted 
on the delivery analgesia have focused on reducing the 
dose of local anaesthetic to minimize the motor block. 
Opioids were added to the low‑dose local anesthetic in an 
effort to reduce the motor block. Minimizing the motor 
block enables a pregnant woman to move independently 
during delivery, and contractions are maintained without 
pain.[9‑12] Although contradictory, it is believed that walking 
contributes to the progression of labor.[13,14] Moreover, 
epidural anesthetics reduce uterine contractility by 
suppressing the production of endogenous oxytocin and 
administration of low doses of such drugs may also minimize 
this risk.[15,16]
In the current study, the dose of bupivacaine was reduced to 
0.0625% for the reasons defined above and for preventing 
motor block. One of our concerns was whether this dose 
would ensure analgesia. Therefore, we added 2 mg morphine 
to this group to increase analgesic efficiency.
In the current study, although the VAS score in the first 
45 min was significantly lower in Group BF compared with 
Group BFM, the VAS score was not significantly lower 
toward the end of labor in the morphine‑administered 
group. Moreover, although analgesia satisfaction in the 
morphine administered group was notably poor after the first 
dose, it was high atthe postpartum visit. We believe these 
outcomes result from the long‑term effects of morphine.
We administered that bolus doses more frequently in the 
morphine group to ensure sufficient analgesia during the 
first hours of labor because analgesic satisfaction following 
the first dose was poorer in this group; however, despite 
frequent administration of the drug, the total dose of the 
local anesthetic administered was significantly lower in this 
group and no motor block was observed.
Studies have demonstrated that continuous epidural 
infusion of local anesthetic and frequently repeated bolus 
doses may increase the total dose of the local anesthetic, 
resulting in motor block.[16,17]
In a study comparing continuous epidural infusions of 
0.0625% bupivacaine/0.0002% fentanyl and 0.0125% 
bupivacaine,[18] the total dose of bupivacaine in the low‑dose 
group was higher than in the group receiving a similar 
treatment in our study (67 ± 32 mg vs. 34.4 ± 17.05 mg 
in our study). Moreover, a high level of satisfaction with the 
analgesia was reported by 88% of the patients during the 
first stage of the labor and in 59% of the patients during the 
second stage. In this study, all solutions were administered as 
continuous infusions, and bupivacaine was also administered 
as a bolus if sufficient analgesia could not be achieved. This 
approach increased the volume of the local anesthetic and 
also resulted in motor weakness. Despite poor analgesia 
satisfaction in the low‑dose group and the resultant 
increased frequency of bolus administration in the current 
study, the total dose of bupivacaine was lower, no motor 
block was observed, and sufficient analgesia was ensured 
for the first and second stages of labor. The reason for 
administering alower dose of the local anaesthetic was due to 
the administration of bupivacaine via an intermittent bolus 
approach. Epidural bolus doses were administered whenever 
required without a time limitation, and the required dose 
of bupivacaine, which was significantly reduced due to 
analgesic efficiency, increased with morphine.
Morphine is one of the primary opioids used in labor 
analgesia. It was demonstrated in humans that morphine 
administered via an epidural route enables efficient and 
long‑term relief for chronic and postoperative pain without 
leading to a sympathetic or neuromuscular blockade.[19] 
Such characteristics of morphine can be advantageous 
for labor analgesia. The reasons for selecting the opioids 
fentanyl and morphine are the rapid onset of the effect of 
fentanyl and the long‑term effect of morphine.
In the current study, we demonstrated that low‑dose 
morphine added to low‑dose bupivacaine together with 
the local anesthetic ensures efficient analgesia, and it can 
be used for labor analgesia without leading to any adverse 
neonatal or maternal effects. In recent years, there are 
no studies using epidural morphine as regional analgesic 
method in vaginal deliveries. In a study conducted by 
Hughes et al.,[20] sufficient analgesia was not achieved in 
Table 4: Conduct of labor and foetal outcomes
BF BFM P value
Total dose of bupivacaine (mg) 47.4±14.28 34.4±17.05 0.0001**
Total dose of fentanyl (mg) 94.8±28.55 105.9±51.95 0.150
Motor block ‑ ‑
First stage of labour (min) 741.8±383.9 810.2±352.6 0.311
Secondstage of labour (min) 25.8±12.5 20.5±12.5 0.027*
Thirdstage of labour (min) 7.7±2.8 6.1±3.0 0.003**
Duration of labour (min) 758.07±382.1 852.86±342.2 0.168
Apgar score
1 min 8.8±0.62 8.7±0.91 0.485
5 min 10.0±0.00 10.0±0.18 0.156
Umbilical artery pH 7.37±0.07 7.35±0.08 0.249
Maximal oxytocin dose 
mIU/min
15.50±2.30 14.80±2.15 0.06
All values are expressed as the mean±standard deviation. BF=Bupivacaine, 
fentanyl group; BFM=Bupivacaine, fentanyl, and morphine group; There is a 
significant reduction in the total dose of bupivacaine in group bupivacaine, 
fentanyl, and morphine, P=0.0001; The second and third stages of labor were 
significantly shorter in Group bupivacaine, fentanyl, and morphine (P=0.027 
and P=0.003)
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any patients who were administered 2 mg and 5 mg of 
epidural morphine. In 7 of 11 patients in the morphine 
group (7.5 mg), analgesia was achieved until the end of the 
first stage of labor and all patients were given bupivacaine 
to provide sufficient analgesia. In the group that received 
7.5 mg morphine, pain relief began 20‑45 min after the 
administration of the drug. This may be perceived as a 
long time by pregnant women experiencing acute pain. 
However, it was reported that 5 mg morphine administered 
via an epidural route ensured long‑term analgesia in the 
postoperative period.[21] This is due to the difficulty of 
blocking the afferent nerves responsible for acute pain and 
the delay of this blockade. Such problems can be overcome 
by ensuring more intense analgesia based on concurrent use 
of morphine with the local anesthetic.
In a study that focused on this problem,[22] 2 mg epidural 
morphine combined with 0.25% bupivacaine was reported 
to result in effective analgesia, and when compared with 
0.25% bupivacaine alone, the duration of analgesia was 
longer and the quality was higher. Our results were similar 
to those of the mentioned study; however, we achieved 
efficient analgesia even with a lower dose of bupivacaine. 
However, we were unable to find any information regarding 
the total dose of bupivacaine in the mentioned study.
Morphine ensures effective analgesia by stimulating Mu 
receptors, but it is also associated with undesirable side 
effects. The use of epidural or intrathecal morphine 
for labor analgesia is limited due to concerns regarding 
such side effects (nausea, vomiting, pruritus, and urinary 
retention), particularly respiratory depression.[23,24] It has 
been suggested that epidural morphine results in emetic 
effects by activating opioid receptors in the chemoreceptor 
trigger zone.[24] Moreover, the pregnancy status and the 
further intensification ofthe delay of gastric passage caused 
by opioids in pregnant women may lead to nausea and 
vomiting.
In our study, we observed nausea and vomiting as side 
effects in eight patients in the group that received morphine. 
Neither side effect persisted nor these women require any 
therapy.
Respiratory depression is one of the most significant problems 
observed after opioids such as hydrophilic morphine are 
administered via a neuraxial route, and it is dependent 
onthe dose of the opioid.[25] This effect may occur at 6‑18 h 
following administration due to the slow rostral diffusion 
and absorption of morphine in the respiration centers.[25] 
The incidence of respiratory depression in obstetric patients 
who received morphine via a neuraxial route was lower than 
that in nonobstetric patients.[19] Although the incidence 
of respiratory depression is low in pregnant women, it is a 
serious risk. Therefore, the respiration, oxygenation, and 
sedation levels of the mother should be closely monitored 
throughout the labor and the postpartum period. We also 
monitored the patients’ respiratory rates and sedation levels 
for 24 h. No evidence of respiratory depression was observed. 
A possible benefit of using a low‑dose local anesthetic in 
combination with narcotics is the minimization of the side 
effects and toxic effects of those drugs on the mother and 
foetus that may occur secondarily to their intravascular and 
intrathecal administration.
Maternal effects of neuraxial opioids also have direct and 
indirect influences on the foetus. If the mother develops 
respiratory depression, the foetus will also indirectly 
develop respiratory depression, and epidural morphine 
has been demonstrated to cross the placental barrier.[26] 
Although very rare previous studies have suggested that 
a continuousepidural infusion of opioids may result in 
an accumulation of the drug and neonatal respiratory 
depression.[27]
In our study, we observed that adding low‑dose morphine to 
bupivacaine had no adverse effect on the foetus. The dose 
of morphine administered in the current study was low, and 
it was only added to the baseline bolus dose. The Apgar 
scores of neonates at the 1st and 5th min were high, and the 
values obtained from umbilical artery blood gas analysis 
were normal. These results correspond to the results of the 
study conducted by Abboud et al.[22] They also added 2 mg 
morphine to bupivacaine, and they observedno adverse 
effect on the foetus.
One contradictory issue associated with labor analgesia is 
related to the effects of neuraxial analgesia on the second 
stage of the labor and the incidence of instrumental delivery. 
The American College of Obstetricians and Gynecologists 
defines a prolonged second stage in nulliparous women as 
lasting more than 3 h with neuraxial analgesia; for parous 
women with neuraxial analgesia, a prolonged second stage 
is defined as more than 2 h. The use of a local anesthetic at 
a high concentration may result in relaxation of the pelvic 
floor muscles. Straining movements are accomplished by the 
pelvic floor muscles, which plays an important role in labor. 
Reducing the motor blockade of these muscles facilitates the 
descent of the foetal head into the pelvis and rotation of the 
foetal head; but it also enables coordinated push strength on 
the foetus throughout the second stage of labor.[28]
Prolongation of the second stage and the need for instrumental 
delivery may cause morbidity ofthe mother, and it may also 
have a negative effect on maternal satisfaction during 
labor.[29] Although it has been speculated that despitethe 
possible correlation between epidural labor analgesia and the 
increase in incidence of instrumental delivery, it is difficult to 
discern whether these instrumental deliveries were elective. 
For the most part, obstetricians prefer elective instrumental 
delivery in women with analgesia.[29] No instrumental 
deliveries were observed in our study.
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Certain studies suggest that epidural analgesia mayshorten 
the second stage of delivery, while other studies demonstrate 
no change.
Although the difference was minor, the duration of the 
second stage of delivery was significantly shorter in the 
low‑dose group compared with the other group in our study.
In another study,[28] patients given 0.25% bupivacaine and 
2 µg/mL fentanyl + 0.1% bupivacaine demonstrated a 
reduction in the duration of the second stage. In our study, 
the duration of the second stage of labor was shorter despite 
the similarity of the administered volume of bupivacaine at 
the same dose [45 (35‑50) mg in the study mentioned and 
47.4 ± 14.28 mg in our study].
In another study,[30] analgesia during the second stage was 
ensured with the continuous epidural infusion of 0.0625% 
bupivacaine and 2 µg/mLfentanyl. There was no statistically 
significant difference between the two groups in terms 
of the duration of the second stage of labor. In the study 
mentioned, the duration of the second stage was 53 min in 
the treatment group.
In our study, the duration of the second stage of labor was 
25.8 ± 12.5 min in Group BF and 20.5 ± 12.5 min in 
Group BFM, and the recorded durations were shorter than 
the duration of the second stage in the study mentioned 
above. This may result from the continuous infusions 
of the solutions in our study or from the lower dose of 
bupivacaine administered compared with the bupivacaine 
dose administered in the other study (47 and 34 mg in our 
study vs. 63 and 44 mg in the study mentioned above).
If morphine had been added while the dose of the local 
anesthetic was kept constant in one of the two groups in our 
study, the need to reduce the local anesthetic could have 
been determined more objectively. However, we surmised 
in our preliminary studies that the local anesthetic used at 
this dose may have provided sufficient analgesia.
Conclusion
We believe epidural analgesia comprised of a low‑dose local 
anesthetic and 2 mg morphine can provide a painless labor 
with efficient analgesia despite the reduction the useof local 
anesthetic. Furthermore, this method of analgesia ensures 
good maternal satisfaction without leading to adverse effects 
on the mother or the foetus, and it slightly (but significantly) 
shortens the second stage of labor.
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